GB201002243D0 - Respiratory disease treatment - Google Patents

Respiratory disease treatment

Info

Publication number
GB201002243D0
GB201002243D0 GBGB1002243.2A GB201002243A GB201002243D0 GB 201002243 D0 GB201002243 D0 GB 201002243D0 GB 201002243 A GB201002243 A GB 201002243A GB 201002243 D0 GB201002243 D0 GB 201002243D0
Authority
GB
United Kingdom
Prior art keywords
respiratory disease
disease treatment
treatment
respiratory
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1002243.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Therapeutics Ltd
Original Assignee
Argenta Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Therapeutics Ltd filed Critical Argenta Therapeutics Ltd
Priority to GBGB1002243.2A priority Critical patent/GB201002243D0/en
Publication of GB201002243D0 publication Critical patent/GB201002243D0/en
Priority to PCT/GB2011/050226 priority patent/WO2011098801A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
GBGB1002243.2A 2010-02-10 2010-02-10 Respiratory disease treatment Ceased GB201002243D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1002243.2A GB201002243D0 (en) 2010-02-10 2010-02-10 Respiratory disease treatment
PCT/GB2011/050226 WO2011098801A1 (en) 2010-02-10 2011-02-09 Inflammatory disease treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1002243.2A GB201002243D0 (en) 2010-02-10 2010-02-10 Respiratory disease treatment

Publications (1)

Publication Number Publication Date
GB201002243D0 true GB201002243D0 (en) 2010-03-31

Family

ID=42110507

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1002243.2A Ceased GB201002243D0 (en) 2010-02-10 2010-02-10 Respiratory disease treatment

Country Status (2)

Country Link
GB (1) GB201002243D0 (en)
WO (1) WO2011098801A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
RU2483743C1 (en) * 2012-06-13 2013-06-10 Зухра Фаниловна Эделева Method of treating rhinitis
JP6800013B2 (en) 2013-03-14 2020-12-16 ポクセル・ソシエテ・アノニムＰｏｘｅｌ ＳＡ Deuterated 2,4-thiazolidinedione and treatment methods
EP3089748A4 (en) * 2014-01-02 2017-09-27 Massachusetts Eye & Ear Infirmary Treating ocular neovascularization
US10188639B2 (en) 2014-01-15 2019-01-29 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
RU2712235C1 (en) * 2019-05-16 2020-01-27 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Agent with a glycosylated polypeptide and a method for production thereof
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0147716A3 (en) 1983-12-24 1987-10-28 ANT Nachrichtentechnik GmbH Method and apparatus for the encipherable transmission of a series of binary information signals with authenticity check
JPS6235216A (en) 1985-08-09 1987-02-16 Noritoshi Nakabachi Method and device for measuring thickness of heterogeneous material layer nondestructively
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
WO1993018007A1 (en) 1992-03-13 1993-09-16 Tokyo Tanabe Company Limited Novel carbostyril derivative
US6362371B1 (en) 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
GB2361337B (en) 1998-10-06 2003-11-12 Spalding Sports Worldwide Inc Printing indicia on game balls
SI20116A (en) 1998-12-02 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Novel procedure of preparation of simvastatine and its analogues
US6204288B1 (en) 1999-03-08 2001-03-20 The University Of Mississippi 1,2-dithiolane derivatives
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
GB9908647D0 (en) 1999-04-15 1999-06-09 Smithkline Beecham Plc Novel compounds
US6683115B2 (en) 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
OA11558A (en) 1999-12-08 2004-06-03 Advanced Medicine Inc Beta 2-adrenergic receptor agonists.
HUP0300832A2 (en) 2000-04-27 2003-08-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel, slow-acting betamimetics, a method for their production and their use as medicaments and pharmaceutical compositions containing them
DE10346940B3 (en) 2003-10-06 2005-06-16 Schering Ag Substituted pentanols, their use for the preparation of medicaments, in particular anti-inflammatories and pharmaceutical compositions containing them
CN1294142C (en) 2000-08-05 2007-01-10 葛兰素集团有限公司 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
WO2002013812A1 (en) 2000-08-17 2002-02-21 Pershadsingh Harrihar A Methods for treating inflammatory diseases
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
WO2002070490A1 (en) 2001-03-08 2002-09-12 Glaxo Group Limited Agonists of beta-adrenoceptors
EP1370521B1 (en) 2001-03-22 2007-12-19 Glaxo Group Limited Formanilide derivatives as beta2-adrenoreceptor agonists
EP1395604B1 (en) 2001-06-12 2008-06-25 Glaxo Group Limited Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives
KR100912324B1 (en) 2001-09-14 2009-08-14 글락소 그룹 리미티드 Phenethanolamine derivatives for treatment of respiratory diseases
WO2003042229A1 (en) 2001-11-12 2003-05-22 Glaxo Group Limited Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
WO2003042160A1 (en) 2001-11-13 2003-05-22 Theravance, Inc. Aryl aniline beta-2 adrenergic receptor agonists
WO2003048181A1 (en) 2001-12-01 2003-06-12 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
AU2003201693A1 (en) 2002-01-21 2003-09-02 Glaxo Group Limited Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
GB0204719D0 (en) 2002-02-28 2002-04-17 Glaxo Group Ltd Medicinal compounds
ES2298511T3 (en) 2002-04-25 2008-05-16 Glaxo Group Limited DERIVATIVES OF PHENETHANOLAMINE.
WO2003099764A1 (en) 2002-05-28 2003-12-04 Theravance, Inc. ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
PE20050130A1 (en) 2002-08-09 2005-03-29 Novartis Ag ORGANIC COMPOUNDS
GB0220730D0 (en) 2002-09-06 2002-10-16 Glaxo Group Ltd Medicinal compounds
DE10246374A1 (en) 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg New 4-(2-alkylamino-1-hydroxyethyl)-3-alkoxy-benzene-1,2-diol derivatives, are beta-mimetics having a long duration of action, useful e.g. for treating asthma, chronic obstructive pulmonary disease or arrhythmia
EP1440966A1 (en) 2003-01-10 2004-07-28 Pfizer Limited Indole derivatives useful for the treatment of diseases
DE60320439T2 (en) 2002-10-11 2009-05-20 Pfizer Inc. INDOIND DERIVATIVES AS β2-AGONISTS
DE60315492T2 (en) 2002-10-22 2008-04-24 Glaxo Group Ltd., Greenford MEDICALLY USEFUL ARYLETHANOLAMINE COMPOUNDS
EP1556342B1 (en) 2002-10-28 2008-03-26 Glaxo Group Limited Phenethanolamine derivative for the treatment of respiratory diseases
GB0225030D0 (en) 2002-10-28 2002-12-04 Glaxo Group Ltd Medicinal compounds
GB0225535D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Medicinal compounds
GB0225540D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Medicinal compounds
DE10253220A1 (en) 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg New 2-(N-phenylalkyl-amino)-1-phenyl-ethanol derivatives, are beta-adrenergic agents especially useful for treating inflammatory and obstructive respiratory diseases such as asthma or COPD
DE10253282A1 (en) 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10258695A1 (en) 2002-12-16 2004-06-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg New 2-(2-hydroxy-2-(3-methylsulfonylamino-4-hydroxyphenyl)ethylamino-4-(pyrid-2-ylamino)-2-methylbutane used e.g. for treating asthma and chronic obstructive pulmonary disease
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
EP1460064A1 (en) 2003-03-14 2004-09-22 Pfizer Limited Indole-2-carboxamide derivatives useful as beta-2 agonists
US7317102B2 (en) 2003-04-01 2008-01-08 Theravance, Inc. Diarylmethyl and related compounds
PL1613315T3 (en) 2003-04-04 2009-07-31 Novartis Ag Quinoline-2-one-derivatives for the treatment of airways diseases
MXPA05011892A (en) 2003-05-08 2006-05-25 Applied Extrusion Technologies Methods of making thick, highly oriented, opaque, low-density, microporous polyolefin films and the films made thereby.
US7268147B2 (en) 2003-05-15 2007-09-11 Pfizer Inc Compounds useful for the treatment of diseases
DE602004021921D1 (en) 2003-05-28 2009-08-20 Theravance Inc AZABICYCLOALKAN COMPOUNDS AS MUSCARIN RECEPTOR ANTAGONISTS
GB0312832D0 (en) 2003-06-04 2003-07-09 Pfizer Ltd 2-amino-pyridine derivatives useful for the treatment of diseases
ES2298757T3 (en) 2003-06-04 2008-05-16 Pfizer Inc. DERIVATIVES OF Z-AMINO-PIRIDINA AS BETA-2 ADRECORRECEPTORS AGONISTS.
CA2531060A1 (en) 2003-07-01 2005-01-13 Schering Aktiengesellschaft Heterocyclically-substitued pentanol derivatives, process for their production and their use as anti-inflammatory agents
WO2005033121A2 (en) 2003-10-03 2005-04-14 King Pharmaceuticals Research & Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
DE10347385A1 (en) 2003-10-08 2005-05-12 Schering Ag Rearranged pentanols, a process for their preparation and their use as anti-inflammatory agents
JP4638438B2 (en) 2003-10-08 2011-02-23 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト Tetrahydronaphthalene derivatives, methods for their production and their use as anti-inflammatory agents
GB0323701D0 (en) 2003-10-09 2003-11-12 Glaxo Group Ltd Formulations
GB0324654D0 (en) 2003-10-22 2003-11-26 Glaxo Group Ltd Medicinal compounds
GB0324886D0 (en) 2003-10-24 2003-11-26 Glaxo Group Ltd Medicinal compounds
GB0328490D0 (en) 2003-12-09 2004-01-14 Glaxo Group Ltd Medicinal compounds
GB0329182D0 (en) 2003-12-17 2004-01-21 Glaxo Group Ltd Chemical compounds
US7959796B2 (en) 2003-12-19 2011-06-14 Shell Oil Company Systems, methods, and catalysts for producing a crude product
DE102004001413A1 (en) 2004-01-09 2005-08-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of chronic obstructive pulmonary disease
TW200531692A (en) 2004-01-12 2005-10-01 Theravance Inc Aryl aniline derivatives as β2 adrenergic receptor agonists
BRPI0507085A (en) 2004-01-22 2007-06-19 Pfizer sulfonamide derivatives, pharmaceutical composition, uses, processes for preparation and combination
ATE369333T1 (en) 2004-01-22 2007-08-15 Pfizer SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
DE102004003428A1 (en) 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting beta-2 agonists, and their use as pharmaceuticals
ATE479433T1 (en) 2004-02-14 2010-09-15 Boehringer Ingelheim Int NEW LONG-ACTING BETA-2 AGONISTS AND THEIR USE AS MEDICINAL PRODUCTS
WO2005092861A1 (en) 2004-03-11 2005-10-06 Pfizer Limited Quinolinone derivatives pharmaceutical compositions containing them and their use
EP1577292A1 (en) 2004-03-17 2005-09-21 Pfizer Limited Phenylaminoethanol derivatives as beta2 receptor agonists
EP1577306A1 (en) 2004-03-17 2005-09-21 Boehringer Ingelheim Pharma GmbH & Co.KG novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases
HN2004000023A (en) 2004-03-22 2007-11-23 Mars Inc ANIMAL MASCADURE
WO2005092860A1 (en) 2004-03-23 2005-10-06 Pfizer Limited Compounds for the treatment of diseases
BRPI0507877A (en) 2004-03-23 2007-07-24 Pfizer formamide derivatives, pharmaceutical composition, use thereof and combination
JP4108117B2 (en) 2004-03-23 2008-06-25 ファイザー・インク Compounds for treating diseases
WO2005092841A1 (en) 2004-03-23 2005-10-06 Pfizer Limited Compounds having beta-agonist activity
JP2007537187A (en) 2004-05-13 2007-12-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Hydroxy-substituted benzofused heterocyclic compounds for use as beta agonists in the treatment of respiratory diseases
EP1595873A1 (en) 2004-05-13 2005-11-16 Boehringer Ingelheim Pharma GmbH & Co.KG Substituted cycloalkyl derivatives for the treatment of respiratory diseases
DE102004024454A1 (en) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals
DE102004024451A1 (en) 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations for inhalation containing enantiomerically pure beta agonists
RU2006146042A (en) 2004-06-03 2008-07-20 Тереванс DIAMINE AGONISTS OF 2-ADRENERGIC RECEPTORS
WO2006014704A1 (en) 2004-07-21 2006-02-09 Theravance, Inc. DIARYL ETHER β2 ADRENERGIC RECEPTOR AGONISTS
WO2006016245A1 (en) 2004-08-05 2006-02-16 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
EP1786762A2 (en) 2004-09-10 2007-05-23 Theravance, Inc. Amidine substituted aryl aniline compounds
DE102004045648A1 (en) 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg New betamimetics for the treatment of respiratory diseases
WO2006051373A1 (en) 2004-11-12 2006-05-18 Pfizer Limited Compounds for the treatment of diseases
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
WO2007100027A1 (en) 2006-03-02 2007-09-07 Daiichi Sankyo Company, Limited Optically active thiazolidinedione derivative
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
GB0702459D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 669
GB0704000D0 (en) 2007-03-01 2007-04-11 Astrazeneca Ab Salts 670
GB2465897B (en) * 2008-08-07 2011-02-09 Argenta Discovery Ltd Respiratory disease treatment

Also Published As

Publication number Publication date
WO2011098801A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
EP2629736A4 (en) Tissue treatment
EP2621588A4 (en) Methods and compositions for disease treatment using inhalation
EP2793986A4 (en) Respiratory treatment system including physiological sensors
GB2465897B (en) Respiratory disease treatment
PL2652193T3 (en) Treatment
EP2618878A4 (en) Therapeutic vaporizer
ZA201205829B (en) Treatment of respiratory disorders
EP2679140A4 (en) Medical endoscope system
GB201002243D0 (en) Respiratory disease treatment
EP2861244A4 (en) Sleep apnea treatment
EP2544686A4 (en) Combination methods for treatment of disease
GB201015822D0 (en) Medical ruggedised case
GB201002224D0 (en) Respiratory disease treatment
GB201013573D0 (en) Treatment
IL232239A0 (en) Medical use
EP2601954A4 (en) Therapeutic agent for disease
IL228589A0 (en) Therapeutic treatment
ZA201207696B (en) Compound for treatment of respiratory condition or disease
GB201014097D0 (en) Treatment
GB201002235D0 (en) Respiratory disease treatment
GB201001903D0 (en) Respiratory disease treatment
GB2477540A8 (en) Respiratory disease treatment
GB0901832D0 (en) Respiratory disease treatment
GB0901831D0 (en) Respiratory disease treatment
GB0910944D0 (en) Respiratory disease treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)